Tomas Ganz americký lékař
Ganz, Tomáš, 1948-
VIAF ID: 54168590422718222063 (Personal)
Permalink: http://viaf.org/viaf/54168590422718222063
Preferred Forms
-
100 1 _ ‡a Ganz, Tomáš, ‡d 1948-
-
100 0 _
‡a
Tomas Ganz
‡c
americký lékař
4xx's: Alternate Name Forms (11)
Works
| Title | Sources |
|---|---|
| Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload |
|
| Microanalysis of antimicrobial properties of human fluids |
|
| Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency |
|
| Microbiology: Gut defence |
|
| Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera |
|
| Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload |
|
| Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis |
|
| A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo |
|
| Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project |
|
| Molecular and clinical correlates in iron overload associated with mutations in ferroportin. |
|
| The molecular basis of ferroportin-linked hemochromatosis |
|
| Molecular cloning and tissue expression of porcine beta-defensin-1. |
|
| Molecular control of iron transport |
|
| The molecular mechanism of hepcidin-mediated ferroportin down-regulation |
|
| Molecular pathogenesis of anemia of chronic disease |
|
| Monocyte-chemotactic activity of defensins from human neutrophils |
|
| Mouse models of anemia of cancer |
|
| Murine 32D c13 cells--a transfectable model of phagocyte granule formation |
|
| Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis |
|
| The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study |
|
| Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier |
|
| Neutrophil defense in patients undergoing bone marrow transplantation: bactericidal/permeability-increasing protein (BPI) and defensins in graft-derived neutrophils. |
|
| Newborn rabbit alveolar macrophages are deficient in two microbicidal cationic peptides, MCP-1 and MCP-2. |
|
| The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment |
|
| Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease |
|
| The opsonizing ligand on Salmonella typhimurium influences incorporation of specific, but not azurophil, granule constituents into neutrophil phagosomes |
|
| Overexpression and structural study of the cathelicidin motif of the protegrin-3 precursor. |
|
| Oxygen-independent bactericidal systems. Mechanisms and disorders |
|
| P105 Decrease in intra- and extra-cellular free iron species and oxidative stress parameters and increase in serum and urinary hepcidin during treatment with deferasirox in iron-loaded patients with MDS |
|
| Paneth cell trypsin is the processing enzyme for human defensin-5. |
|
| Paneth cells--guardians of the gut cell hatchery |
|
| Polymorphic expression of defensins in neutrophils from outbred rats |
|
| Porcine epithelial beta-defensin 1 is expressed in the dorsal tongue at antimicrobial concentrations |
|
| Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins |
|
| A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron |
|
| Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin |
|
| Preface: iron and cancer |
|
| Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease |
|
| Primary structures of three human neutrophil defensins |
|
| The pro region of human neutrophil defensin contains a motif that is essential for normal subcellular sorting. |
|
| Proinflammatory state, hepcidin, and anemia in older persons |
|
| Protegrins: new antibiotics of mammalian origin |
|
| Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice |
|
| Purification and antimicrobial properties of three defensins from rat neutrophils |
|
| Purification and characterization of defensins from cystic fibrosis sputum |
|
| Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics |
|
| Reduced Paneth cell alpha-defensins in ileal Crohn's disease |
|
| Reduced serum hepcidin levels in patients with chronic hepatitis C. |
|
| Reduction of serum hepcidin by hemodialysis in pediatric and adult patients |
|
| Regulation of human beta-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. |
|
| Regulation of iron acquisition and iron distribution in mammals |
|
| Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization |
|
| Retraction Notice to: The Hepcidin-Binding Site on Ferroportin Is Evolutionarily Conserved |
|
| Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis |
|
| Rings of destruction |
|
| The role of hepcidin in iron metabolism |
|
| The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study |
|
| The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids. |
|
| Sequential evaluation of serum hepcidin in anemic myeloma patients: Study of correlations with myeloma treatment, disease variables, and anemia response |
|
| Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors |
|
| Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'-UTR of the HAMP gene |
|
| Small cyclic agonists of iron regulatory hormone hepcidin |
|
| Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site |
|
| The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis |
|
| Stripline coupling to Josephson oscillators |
|
| Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation |
|
| Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin |
|
| The structure of porcine protegrin genes |
|
| Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39. |
|
| Suppression of hepcidin during anemia requires erythropoietic activity |
|
| Synergistic activity of rabbit granulocyte peptides against Candida albicans |
|
| Synergistic cytolysis mediated by hydrogen peroxide combined with peptide defensins |
|
| Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs |
|
| Systemic iron homeostasis |
|
| Testing the iron hypothesis in a mouse model of atherosclerosis |
|
| Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin |
|
| Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis |
|
| TGF-alpha regulates TLR expression and function on epidermal keratinocytes |
|
| Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype. |
|
| Thiol-derivatized minihepcidins retain biological activity. |
|
| A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis |
|
| Understanding the structure/activity relationships of the iron regulatory peptide hepcidin |
|
| Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis |
|
| Urinary hepcidin in congenital chronic anemias |
|
| Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors |
|
